Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SP

In the past licensing news hasn't moved the pps much and often we would end up with a loss for the day. The reason is simple... all we're getting for our efforts are nuisance fees, no substantial settlement monies. Although we did show a small gain in this quarterly report I doubt it will move the pps up much if at all for the same reasons. We've simply GOT to get more money for our licensing efforts, at least on a par with other companies that license their patents for a fee. JMO of course.

Share
New Message
Please login to post a reply